Barbara M. Wollersheim

Papers

Total Citations

H-Index

About

Barbara M. Wollersheim is a leading researcher in personalized oncology and shared decision-making, with a focus on improving outcomes for patients with localized prostate cancer. Her work centers on developing individualized risk prediction models to guide treatment choices, particularly regarding urinary incontinence after prostatectomy. In her highly cited 2021 study (18 citations), she demonstrated that providing patients with personalized risk estimates for incontinence—rather than standardized information—significantly influenced treatment decisions, empowering men to make more informed choices aligned with their values. This research bridges the gap between clinical data and patient-centered care, highlighting her commitment to translating predictive analytics into practical tools for shared decision-making. Wollersheim’s contributions are notable for their direct impact on clinical practice, offering a model for how risk stratification can enhance patient autonomy and quality of life. Her work continues to shape the integration of individual risk communication in urologic oncology, making her a pivotal figure in advancing personalized medicine.